Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Tushar Date"'
Autor:
Dasharath Chaudhari, Kaushik Kuche, Vivek Yadav, Rohan Ghadi, Tushar Date, Nallamothu Bhargavi, Sanyog Jain
Publikováno v:
Drug delivery and translational research.
In present investigation, we developed paclitaxel (PTX)-loaded adenosine (ADN)-conjugated PLGA nanoparticles for combating triple-negative breast cancer (TNBC), where ADN acts as a substrate for adenosine receptors (AR) that are overexpressed in TNBC
Autor:
Sanyog Jain, Narinder Kumar, Reena Sharma, Rohan Ghadi, Tushar Date, Nallamothu Bhargavi, Dasharath Chaudhari, Sameer S. Katiyar
Publikováno v:
Drug delivery and translational research.
Sildenafil (SLD) is employed for the management of erectile dysfunction and pulmonary arterial hypertension. It exhibits meagre water solubility and is available in the form of citrate salt hydrate to improve the solubility. However, it still exhibit
Autor:
Sanyog Jain, Venkat Pattewad, Nallamothu Bhargavi, Sheetal Yadav, Reena Sharma, Rohan Ghadi, Tushar Date, Sameer S. Katiyar, Dasharath Chaudhari, Kaushik Kuche, Rahul R. Mahajan
Publikováno v:
Journal of Drug Delivery Science and Technology. 84:104435
Autor:
Dasharath Chaudhari, Oly Katari, Rohan Ghadi, Kaushik Kuche, Tushar Date, Nallamothu Bhargavi, Sanyog Jain
Publikováno v:
ACS biomaterials scienceengineering. 8(8)
Triple-negative breast cancer (TNBC) belongs to the category of the most destructive forms of breast cancer. Being a highly potent chemotherapeutic agent, paclitaxel (PTX) is extensively utilized in the management of various cancers. Commercially ava
Autor:
Tushar Date, Kaushik Kuche, Dasharath Chaudhari, Rohan Ghadi, Deepak Kumar Sahel, Deepak Chitkara, Sanyog Jain
Publikováno v:
ACS biomaterials scienceengineering. 8(6)
Triple-negative breast cancer (TNBC) cells show improved sensitivity for cisplatin therapy due to their defective DNA damage repair system. However, the clinical utilization of cisplatin is limited by dose-dependent systemic toxicities and chemoresis
Publikováno v:
Molecular pharmaceutics. 19(5)
Cisplatin is a platinum (Pt)-based anticancer drug with broad-scale clinical utility. However, due to its hydrophilic nature and high kinetic reactivity, it offers numerous drug delivery challenges. Limitations such as severe systemic toxicities, che
Autor:
Md. Meraj Ansari, Kaushik Kuche, Rohan Ghadi, Tushar Date, Dasharath Chaudhari, Faiyaz Ahmad Ansari, Rehan Khan, Akshay Vyawahare, Sanyog Jain
Publikováno v:
Emerging Modalities in Mitigation of Antimicrobial Resistance ISBN: 9783030841256
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::85c1fbeb5ff33fffa91d3bdc5e4c5ac6
https://doi.org/10.1007/978-3-030-84126-3_18
https://doi.org/10.1007/978-3-030-84126-3_18
Publikováno v:
Molecular Pharmaceutics. 16:4519-4529
Amphotericin B (AmB) is one of the most effective drugs used in the treatment of leishmaniasis and systemic fungal infections. Considering the global burden of leishmaniasis, ∼90% of disease cases occur in developing countries, suggestive of the ne
Autor:
Tushar Date, Sameer S. Katiyar, Sanyog Jain, Mahesh Katariya, Rajan Swami, Varun Kushwah, Pragati Khare
Publikováno v:
Nanomedicine. 14:2227-2241
Aim: To design a nanocarrier platform for enhanced transdermal drug permeation. Materials & methods: Gel-based high permeation vesicles (HPVs) were developed and their performance in terms of transdermal flux improvement, in vitro release and skin ir
Autor:
Tushar Date, Rahul R. Mahajan, Sanyog Jain, Tushar Kumeria, Naisarg Pujara, Varun Kushwah, Shesherao M. Dongave, Amirali Popat
Publikováno v:
ACS Biomaterials Science & Engineering. 5:3361-3372
PEGylation (i.e., attachment of polyethylene-glycol) of carbon nanotubes (CNTs) is one of the most widely used strategies to improve its biocompatibility and aqueous dispersion stability, which are critical for their successful clinical application.